Study reveals hyperimmune intravenous immunoglobulin doesn't help COVID-19 patientsThe combination of remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2 is not more effective than remde...
European stocks bounce off lows on virus treatment hopesThe pan-European STOXX 600 index rose 1.3%, mirroring gains for Asian markets after the U.S. health regulator said on Sunday it authorized ...
Scientists are now testing if survivor plasma can prevent Covid-19Thousands of coronavirus patients in hospitals around the world have been treated with so-called convalescent plasma.
- Sanofi plans mega US deal to counter sales dip
Sanofi-Aventis, France’s biggest drugmaker, is preparing a major acquisition in the US, according to five people with knowledge of the situ...
- Spain's Grifols plans to buy Talecris for $3.4 bn
Spanish health care company Grifols plans to expand in the U.S. with the $3.4 billion purchase of plasma company Talecris Biotherapeutics.